Tuberculous hepatitis in renal transplant recipients following alemtuzumab induction therapy

• Main Authors: W. Bosch, N. Poowanawittayakom, K. Chaikriangkrai, J. Mendez, W. C. Hellinger, T. A. Gonwa, M. Krishna, S. Pungpapong
• Other Authors: Mayo Clinic in Jacksonville, Florida
• Format: Article
• Published: 2018
• Subjects: Medicine
• Online Access: https://repository.li.mahidol.ac.th/handle/123456789/32548
• Institution: Mahidol University

Mycobacterium tuberculosis infection is one of many opportunistic infections in renal transplant recipients, arising either from reactivation of latent infection or de novo infection, occasionally donor derived. M. tuberculosis hepatitis has never been reported in patients who have received alemtuzu...